This article considers a decision theoretic method for timing medical examinations. The speci c model is motivated by screening |that is examining asymptomatic individuals for hidden disease or risk-increasing conditions. Ideas and strategies may be applied more broadly to problems in which a stochastic process is monitored over time with a costly and possibly faulty data collection procedure. From a technical viewpoint, the approach of this article is based on modeling the decision space as a space of functions, termed screening intensity functions. Results include explicit rules for deciding whether or not an individual of given age and risk factors should be screened for a disease, and for deciding when an individual examined today should be examined again. For example, in a special case, the optimal frequency of examinations is proportional to the square root of the incidence of the disease. Results are illustrated using data on breast cancer screening. Some key words: Design, Screening, Medical decision making.
Introduction 1 Background
The e cient collection of information on a random process over time can be an important part of practical statistical problems. Data collection procedures are costly, and sometimes reveal only partial information about the process of interest. As a result, models for timing observations have received attention in various areas, including meteorology, production, nance, medicine. In particular, the timing of medical examinations is one area where statistical challenges are interesting, and solutions are likely to have impact on health policy and patient treatment. This paper develops an approach to timing medical examinations. The archetypical application is screening |that is examining asymptomatic individuals for hidden disease or risk-increasing conditions. The paper is framed in this context, but ideas and methods can be applied more broadly.
Screening is the primary way of controlling mortality and morbidity from several illnesses. For example, screening for cancer on a population-wide basis is common in various countries for cancer of the breast, prostate and uterine cervix. Colorectal and ovarian cancer screening have also been considered in recent years. Screening examinations are costly and can sometimes be hazardous to health, so the e ectiveness of a screening program can depend crucially on the program design: Who should be screened? At what age should screening begin and be discontinued? What is the appropriate interval between examinations? Should the interval change according to intervening changes in risk factors?
These and similar questions have prompted decision theoretic approaches to timing medical examinations. Earlier contributions include Lincoln & Weiss (1964) , Weiss & Lincoln (1966) , Kirch & Klein (1974) , Shahani & Crease (1977) , Eddy (1983) , Tsodikov & Yakovlev (1991) , Zelen (1993) , Parmigiani (1993a) . Related models arise in posttreatment surveillance (Tsodikov et.al. 1993 ) and in inspection of randomly failing equip-1 ment (Barlow, Hunter & Proschan 1963 , Parmigiani 1993b . A common solution strategy is to use variants of dynamic programming or recursive dynamic techniques to nd optima in the space of sequences of examination times.
2. Goals
This paper presents an alternative approach for choosing examination times. From a technical viewpoint, the approach is based on approximating the decision space, which is a space of sequences, using a space of functions (Keller 1974) . Methods for nding optima in function spaces, or variational methods, have a long tradition in statistical design (Rustagi, 1976) and can be applied successfully in this case as well. Advantages include: 1) speed of computation; 2) relative simplicity and appeal of the solutions; 3) exibility in incorporating extensions. These are discussed next. One drawback of this approach is that the solution is only an approximation to the actual optimum.
1) Exact solutions to complex timing models (Parmigiani 1993a ) are computing intensive. When the screening tests has sensitivity less than unit, that is it can fail to reveal the disease when it is detectable, nding the optimal times for a xed number n of examinations involves solving a nonlinear system of n equation. Evaluating these equations involves time consuming numerical integration; numerical solutions to the system are often unstable. This procedure needs then to be repeated at di erent levels of n in order to nd the optimal n. In important practical applications, such as breast cancer screening, values of n between 10 and 30 are common, and can typically lead to repeating numerical integration steps around 100,000 times. Using a variational approach, a good approximate solution to the same problem is available by simple numerical inversion of one known function. In nontrivial special cases, the inverse in explicit. Computing speed is especially important in complex decision models, where timing decisions may be nested within a more complex decision process, and where sensitivity analysis is necessary.
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2) The sequence of recursive relations that de ne the exact solutions can be involved and hard to interpret. The variational approach proposed here o ers explicit and more easily interpretable rules for two important aspect of screening: a) whether or not an individual of given age and risk factor pro le should be examined; b) when an individual examined today should be examined again.
3) The variational approach has potential for important extensions, that would be arduous within the standard framework. An important example is adjusting the rules in a) and b) for time varying covariates, known only as a result of the examination. For example, in cervical cancer, it can be helpful to increase the frequency of pap-tests as a result of detection of low grade squamous intraepithelial lesions (Gusta son & Adami 1992 , A.C.O.G. 1995 .
The plan of the paper is as follows. Section 2 reviews the disease model, and formulates the statistical decision problem. The decision space and objective function, accounting for cost of examinations as well as health outcomes, are discussed in detail. Section 3 includes the solution of the optimization problem, some of its properties, and examples. Section 4 discusses the accuracy of the variational approximation in the context of screening for breast cancer.
Problem Formulation
The decision making framework is de ned by a stochastic process for the natural history of the disease, by a decision space, and by an objective function |describing costs and health outcomes associated with each combination of a decision and a disease history.
1. Natural History of Disease
The natural history of a chronic disease is described here by a stochastic compartment model (Manton and Stallard 1988) . Early articles on stochastic models in screening include Zelen and Feinlib (1969) , ) Shwartz (1980 Shwartz and Eddy (1982) . Related multi-state models are used in the carcinogen bioassay literature (Murdoch, Krewski & Crump 1987 , Lagakos & Louis, 1988 ). This article is based on a four-state model with time dependent incidences, an important feature in chronic disease (Parmigiani 1993a) .
The natural history of disease is shown in Figure 1 , which also summarizes the notation. (1) Transition densities are xed. This rules out the situation wherein the screening is carried out both to help individuals and to improve estimates of the disease natural history. However, it is still possible to incorporate uncertainty about the transition densities, as discussed in more detail in Section 6. Screening can be worthwhile for patients only if there is a connection between early detection and patient's well being. Accounting for this requires considering the disease history after detection. In this article, this part of the modelling is incorporated via the objective function, as discussed later. Screening examinations will be assumed not to a ect transition probabilities. A limitation of this assumption is that it excludes the case wherein examinations themselves hasten the development of the disease. However, the clinical history of disease can be a ected by early detection resulting from screening. This e ect is modelled via the objective function L. Screening examinations involve only asymptomatic individuals and end as soon the disease is detected in II, or the individual reaches III (therefore seeking medical advice), or IV, or age n . Patients that become symptomatic between screening examination are tested one more time at that point.
The approach of this paper is based on approximating via a continuous function, termed screening intensity function. This represents the number of examinations per unit of time for an individual in states I or II, and will denoted by s(y). There is no relation between s and the intensity functions used in counting processes. The form of s can be quite general. It is natural to take s to be nonnegative. The only further restriction that is needed for the results of Section 3 to hold is that s should be piecewise continuous.
This strategy has precedents in Keller (1974) , in the context of inspection model for stochastically deteriorating systems.
The plan for using an intensity function in determining examination times is as follows:
1. Develop an approximate objective function that depends on only via s; 2. Find the optimum s; 3. Deterministically nd 's from s. Steps 1 and 2 are discussed in Section 3.
Step 3. can be carried out in at least two ways. Call (y) = 1=s(y) the spacing between examination times at age y. Keller (1974) proposed to use the recursive relation:
This needs s > 0, but can be modi ed to account for the case of s = 0 at some y, as discussed later. Alternatively, the cumulative intensity function
approximates the total number of examinations scheduled between 0 and y. Therefore one can generate based on S( i ) = i i = 1; 2; : : :
Under either (2) or (4), s generates a unique , while the converse does not hold.
The screening strategies considered here depend on age and cancer status, but not on other time varying patient characteristics. A generalization allowing s to depend on time varying covariates measured during the screening examination is possible, as discussed in Section 5. Fixed covariates, such as race or gender, can be modelled via the duration 6 distributions and do not pose any additional challenge to the optimization.
3 Objective Function
The objective function models costs and health outcomes and is based on the following elements: 1. The cost of one examination; 2. The average cost of medical care after detection; 3. The health outcome of interest; 4. The monetary value of one unit of the health outcome. These are discussed in more detail next.
The monetary cost k of one examination is independent of both age and disease state. Here, k incorporates consideration of low speci city of screening examinations. Usually, if the speci city of the screening modality is not su ciently high, positive tests are followed by a further, highly speci c, test. For example, positive mammographies are followed by a biopsy. If there is no disease, the individual continues to be screened. In this way, low speci city a ects costs, through the frequent use of the highly speci c second test.
The monetary cost of medical care after detection is a function of y, u and the mode of detection (II for screen detection and III for interval detection), indicated by C i (y; u), i 2 fII; IIIg. It is an average with respect to possible histories of cost of treatment after detection. These are examples of some of the e ects that can be incorporated via the function C. Screening could lead to decreased cost, by reducing the incidence of complications, or by leading to less aggressive treatment. In other situations screening could lead to increased costs, by prolonging life during treatment or simply by starting treatment earlier. The expected cost of care can also vary with age. In particular older patients are more prone to competing causes to deaths, which may result in lower costs, but are also more prone to complications, which may result in increased costs.
The health outcome of interest is a function of y, u and the mode of termination (II for screen detection, III for interval detection and IV for death prior to detection) indicated by L i (y; u), i 2 fII; III; IV g. Again this is an average with respect to possible dis-ease histories after detection. Natural choices of L include survival, relapse-free survival, quality adjusted survival or other measures of patient's well being. See Kamlet (1991) for a discussion of health outcomes in medical decision making. Many commonly used outcome measures depend on age at diagnosis and length of the preclinical sojourn time. If screening is e ective, they would also depend on mode of detection.
Sometimes, simpler measures of outcome can also be of interest. For example, taking L III (y; u) = 1 and L II (y; u) = L IV (y; u) = 0, gives a xed penalty to reaching the symptomatic stage (see also Zelen 1993) . If the advantages of screening do not depend markedly on age and preclinical sojourn time, this can be a tenable choice, and will be used as illustration later. The appeal, and limitations, of this measure, arise from avoiding the important but potentially complex modelling of disease history after detection. The decision problem can be stated as follows: for a xed screening intensity function s, I(s) is the expected number of examinations, L(s) = E(L) and C(s) = E(C). The objective is the minimization of R(s) = kI(s)+C(s)+cL(s) with respect to s. If increasing L increases patient well-being, c will be negative. The derivation of an approximation to R and properties of the resulting solution are discussed in Section 3. Practical elicitation of c may be di cult. A general discussion in the framework of cost-utility analysis is in Kamlet (1991) . In applications, a useful alternative to direct elicitation of c is the Pareto trade-o curve, graphing the value of L associated with the schedule minimizing L for xed expected cost C 0 (Verdinelli and Kadane 1992, Parmigiani and Kamlet 1993) . First order conditions for constrained and unconstrained optimization are closely related as the Lagrangian for the constrained problem is` kI( ) + C(s) ? C 0 ]+ L( ), which is proportional to our objective function R (see also Clyde and Chaloner 1996) . To simplify the presentation, only the unconstrained problem is considered. This simple Taylor series approximation can be extended to general objective functions. Further complications arise when the test is subject to false negative results. If an individual becomes preclinical at time y, more than one examinations may be necessary to detect the disease. The second approximating technique that will be used assumes that these are equally spaced, at intervals (y). This is likely to work better in practical applications where the number of tests necessary to detect the disease is small, either because the test is e ective, or because the sojourn time is relatively short. Notice that the spacing of the examinations still varies with age.
These two approximation techniques lead to a much simpli ed solution, and appear to perform very well in important practical examples. Formal asymptotic properties as s ?1 ! 0 could be developed along the lines of Keller (1982) , but are not pursued here.
As in the example, we begin by xing y. The total number of screening examinations in (0; y) is approximately S(y). Let j be the probability of a positive results of the j-th screening test following y, conditional on being in state II and undetected. For example, a woman developed detectable breast cancer at age 48, after 3 earlier mammographic exams. She was then examined at age 49 and the tumour was missed; the probability of that happening was 1 ? 1 . She is now 51, still asymptomatic and being examined again. Her probability of testing positive is now 2 . The 's are sensitivity parameters. If test outcomes are independent then all 's are equal. The assumption of independence is not always tenable; for example, circumstances leading to missed tumours can persist from test to test. Further simplifying approximations will be discussed in the context of speci c examples.
2 Optimality Conditions
We now turn to the minimization ofR(s). Even thoughR(s) is approximate, solutions will be called optima. Call J the number of false positive results before a true positive, in absence of transitions from II. J takes the value j with probability j , j = 0; 1; 2; : : :. where X = 2J + 1, and the expectation is with respect to J. This function arises in connection with the partial derivative ofR(s) with respect to s. Interpretation ofL is postponed to simpler illustrative examples. The main tool for the analysis of optimal screening intensity function is the solution to the Euler-Lagrange equation, discussed in the following result. 
where a is a constant. Lemma 2. If y is such that a solution to (5) exists, a = 1 is optimal.
As an immediate corollary, the optimality condition (5) can be rewritten in terms of the incidence of preclinical disease: In this case, the optimal spacing between examinations is increasing with the cost of examinations and decreasing with the incidence of preclinical disease and withL.
In some situations, a solution to (5) may not exists for all values of y or it may not be unique. Also, it is interesting to investigate conditions under which the optimal frequency of examinations is monotonically increasing in ,as above. These questions are considered by the next theorem, that assumes the following three regularity conditions onL(y; u).
i)L(y; u) > 0 for all (y; u); ii) There exists a constant M such that lim u!0L (y; u) < M for all y;
iii) The function u 2L (y; u) is continuous and either monotone or unimodal in u.
Theorem 3. Under conditions i), ii) and iii), the optimal screening intensity function has the following form: if (5) has no solution, s = 0 is the optimum; if (5) has one solution, that is the optimum; if (5) has two solutions, the larger s is the optimum; A su cient condition for i) is that early detection should not be detrimental, and that it should be strictly preferred to death. These are met in many application. A relevant exception occurs when L represents solely treatment costs, in which cases death may result in smaller losses. Regularity condition ii) is not restrictive. To violate this condition one needs an arbitrarily large advantage associated with early detection when the sojourn time is very small. As of regularity condition iii), continuity in u is natural in this context. Monotonicity and unimodality are easy to check in general and satis ed 13 in important special cases. Results can be extended to the multimodal case. This is elaborate and of limited practical interest, so it is omitted.
In practice, many screening programs are based on equally spaced examinations. Equations (6) leads to simple su cient conditions for optimality of equally spaced examinations.
Corollary 5. If the following are independent of age and covariates, than equally spaced examinations are optimal:
i) The incidence of preclinical disease (y);
ii) The distributions of the sojourn time in the preclinical stage h III and h IV ;
iii) The terms L III (y; u)?L II (y; u)], L IV (y; u)?L II (y; u)] and C III (y; u)?C II (y; u)].
These conditions are hard to meet. Condition i), requires that the incidence of a chronic disease is independent of age, and this is rarely the case, unless one considers a narrow age range. However, even though suboptimal, equally spaced examinations will be more practical, and may be preferred. The methods discussed in this paper provide tools for evaluating the advantages of general policies over policies based on equally spaced examinations.
After nding the optimal s, the examination schedule can be determined via (4) or via (2). If s(y) = 0 the next examination can be set at the earliest age, after y, such that s > 0. If s(0) = 0, the rst examination can be scheduled at y 0 or at y 0 + 1=s(y 0 ), where y 0 is the earliest age such that s > 0. Small value of s are typically associated with poorer performance of the approximation. III is the partial derivative with respect to the rst coordinate. When this is small, such as with a nearly uniform sojourn time, a unit increase in the expected number of false negative results before a true positive result leads to roughly halving the optimal spacing.
One choice of h III leading to an explicit inversion of the left hand side of (7) The goal of this section is to illustrate the accuracy of the variational approximation in the context of breast cancer screening. Evidence on the bene ts of breast cancer screening is still con icting. The values utilized here are realistic for the timing problem, but a serious appraisal of breast cancer screening policies would require a much more thorough meta-analysis and decision analysis.
The objective function for this section is L III = 1, L II = L IV = 0, C II = C III = C. In breast cancer, evidence from clinical trials suggests that clinical detection leads to higher mortality and morbidity than detection by screening, so that reaching state III is a useful proxy for more realistic formulations, such as expected length of life, or expected quality adjusted length of life. The tradeo parameters are C = 350k, leading to intervals similar to current recommendations.
The natural history of the disease can be estimated based on epidemiological registries and data from clinical trials. Moolgavkar, Stevens and Lee (1979) estimate the incidence of symptomatic breast cancer by age, providing an empirical density for Y + U. The age distribution of deaths from causes other than breast cancer is found in life tables. Estimation of the distribution of the sojourn time in the pre-clinical stage can be based on screening data and constitutes a very challenging task. Approaches include Louis, Albert & Heghinian (1978) , Walter and Dey (1983) , Etzioni (1993) and Straatman Peer and Verbeek (1994) . In particular, Straatman et al. (1994) analyze breast cancer data from a large clinical trial known as the HIP (Health Insurance Plan of New York). Based on their results, I postulate an exponential sojourn time distribution h III , with mean 2:3. One limitation of using HIP data is that mammographies are now more accurate than they were at the time the trial was conducted. This has consequences on the de nition of state II. Tumours become detectable earlier so that y tends to be smaller and u larger.
Based on these elements, it is possible to derive the distribution of the sojourn time in state I, by deconvolution via Laplace transforms, as discussed in Zelen and Feinlib (1969) .
The resulting density f II (y) and incidence (y) for transitions to the preclinical state are shown in Figure 1 .
Consider rst the case of unit sensitivity (J = 0). Figure 2 compares the exact optimal screening schedule with the schedule based on the variational approximation. The intervals between examinations are approximated very closely. Based on the exact solution, the expected number of examinations is 14:45, while the probability of reaching the clinical state is :0634. Based on the variational solution, the expected number of examinations is 14:60, while the probability of reaching the clinical state is :0635.
To get an indication of the relative performance of the approximate policy relative to the optimal policy, consider the relative increase in the objective function resulting from using the approximate rather than the exact policy. In this example this is only :448%.
The quality of the variational approximation remains excellent on a wide range of values of tradeo parameter k=C, and tends to be better when the frequency of examinations is higher.
There is some di erence between the exact and approximate age of rst examination. The alternative calculation based on expression (4) tends to be less sensitive to spikes in the function 1=s. Table 1 compares the exact times and intervals with both approximation strategies. Strategy (4) approximates the age of rst examination better than strategy (2). From the second examination on, though, (2) is closer to the exact value. As interval between examinations become smaller, the two strategies give very similar intervals, as should be expected. Table 1 : Exact and approximate examination policies for = 1. Column A reports the exact examination times. Column B and C reports the approximate examination times computed based on expressions (2) and (4) respectively. Columns A, B and C report the corresponding intervals. Only the rst ten values are included. Figure 3 compares the screening intensity function, at = 1 and = 1:25 (Straatman, Peer and Verbeek, 1994) , based on approximation (8). Lower sensitivity leads to a higher age of rst examination and more frequent examinations.
Conclusions
This paper proposes a variational approach to timing medical examinations. Variational solutions lead to close approximations of the optimal timing strategies, as illustrated in the breast cancer example. They also o er dramatic advantages in terms of speed of computation. The simple analytic solutions o ered in Section 3, and in particular Section 3.3, highlight the e ects of the main elements of the model on observation intensity. These would be hardly intelligible from the exact optima (Parmigiani 1993a) .
In practical applications, the transition distributions are seldom known with certainty. In particular, sojourn time distributions can be di cult to estimate. Uncertainty arising from the estimation can be incorporated successfully in the design of the screening schedule. One approach is the following. Suppose, to x ideas, that the distributions of y and u are parametric, and that information on parameters is available in the form of a posterior distribution, based on existing studies. Then, the goal is to compute the expected value of the objective function with respect to all unknowns, including y, u and the parameters. As long as the objective function does not depend directly on the parameters, these can be integrated out, and the expectation can be expressed in terms of the marginal distributions of y and u only. In conclusion, by thinking of f's and h's as marginal distributions, one can apply the optimality results to situations where there is uncertainty about transition distributions. An example is provided by Parmigiani & Kamlet (1993) .
In this paper we assumed that the information made available by the screening test is a binary outcome. Sometimes screening tests provide more complete information, including for example changes in risk factors, sub-stages of the preclinical stage, presence of related illnesses or bio-markers (Skates at al. 1995) . It is straightforward to extend this approach the case of stationary time-varying covariates, because, under stationarity, all transition probabilities for the disease states depend on the covariates only through the current value. Results reproduce with suitable notational revisions. Nonstationary covariates are harder to handle.
Other options for extension include accounting for time dependent test sensitivity, important as larger tumours are more easily detected, and modeling richer state spaces, corresponding to di erent disease stages or therapy decisions.
solution also exists for all a 2 1; a 0 ]. Let (a; y) be a value of s solving (5) for a 2 1; a 0 ].
We must minimize R( ) with respect to a. Using (5) Figure 2: Preclinical disease density and incidence. The graph on the left is the density f II of transitions from healthy to preclinical disease. The graph on the right is the incidence of preclinical disease .
